Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
6
×
detroit blog main
detroit top stories
indiana blog main
6
×
indiana top stories
investing
6
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
fda
startups
vertex pharmaceuticals
bristol-myers squibb
cancer immunotherapy
deals
pfizer
roche
biotech ipos
cystic fibrosis
What
roundup
6
×
bio
drug
ahead
annual
asco
attention
biotech
days
fda
growing
advantages
alliance
alzheimer’s
ambien
american
approved
assessed
attendees
bar
branded
brings
bristol
buy
calls
camp’s
cancer
cash
changing
chicago
choices
city
clinical
color
combinations
commissioner
communities
community’s
companies
conference
Language
unset
Current search:
investing
×
roundup
×
" indiana blog main "
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More